STARTING ANTIBIOTIC THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA IN REAL CLINICAL PRACTICE

Abstract

Background. To analyze the real clinical practice of appointment starting antibacterial therapy for patients with community-acquired pneumonia in the Department of Pulmonology of a multidisciplinary hospital and estimate its compliance with clinical recommendation. Materials and methods. In a retrospective study, an analysis was made of 100 case histories and sheets of medical prescriptions for patients hospitalized in the pulmonology department of the Emergency Hospital with a diagnosis of community-acquired pneumonia from July to December 2019. The study included all patients with community-acquired pneumonia, which was diagnosed on the basis of a set of research methods: medical history, clinical-physical and laboratory-radiological data.. Results. The gender distributions of the patients included in the study was 43 women and 57 men. The median age in men was 48 years old, and in women – 55. Severe community-acquired pneumonia was observed in 30% of patients. 1/5 patients received antibacterial therapy on an outpatient basis. Starting antibiotic therapy in the hospital in 93% was combined. Among combinations levofloxacin + ceftriaxone (50%), ampicillin/sulbactam + levofloxacin (31%) and levofloxacin + amoxicillin/clavulanate (19%) prevailed. Combined antibiotic therapy was used in 65%. Conclusion. Initial antibiotic therapy for community-acquired pneumonia in the pulmonary department of a multidisciplinary hospital was prescribed in accordance with clinical recommendations, which reduces the number of complications and mortality from community-acquired pneumonia.

Keywords

• внебольничная пневмония
• антибактериальная терапия
• анализ реальной клинической практики
• стационарное лечение внебольничной пневмонии